Mahlknecht U - Search Results

1

GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.

Fabian J, Lodrini M, Oehme I, Schier MC, Thole TM, Hielscher T, Kopp-Schneider A, Opitz L, Capper D, von Deimling A, Wiegand I, Milde T, Mahlknecht U, Westermann F, Popanda O, Roels F, Hero B, Berthold F, Fischer M, Kulozik AE, Witt O, Deubzer HE. Fabian J, et al. Among authors: mahlknecht u. Cancer Res. 2014 May 1;74(9):2604-16. doi: 10.1158/0008-5472.CAN-13-1904. Epub 2014 Jan 13. Cancer Res. 2014. PMID: 24419085

2

The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines.

Xu Y, Voelter-Mahlknecht S, Mahlknecht U. Xu Y, et al. Among authors: mahlknecht u. Int J Mol Med. 2005 Jan;15(1):169-72. Int J Mol Med. 2005. PMID: 15583844

3

Role of histone deacetylase inhibitors in the treatment of cancer (Review).

Mei S, Ho AD, Mahlknecht U. Mei S, et al. Among authors: mahlknecht u. Int J Oncol. 2004 Dec;25(6):1509-19. Int J Oncol. 2004. PMID: 15547685 Review.

4

The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities.

Zhu JY, Lavrik IN, Mahlknecht U, Giaisi M, Proksch P, Krammer PH, Li-Weber M. Zhu JY, et al. Among authors: mahlknecht u. Int J Cancer. 2007 Oct 15;121(8):1839-46. doi: 10.1002/ijc.22883. Int J Cancer. 2007. PMID: 17565740 Free article.

5

Azacytidine causes complex DNA methylation responses in myeloid leukemia.

Stresemann C, Bokelmann I, Mahlknecht U, Lyko F. Stresemann C, et al. Among authors: mahlknecht u. Mol Cancer Ther. 2008 Sep;7(9):2998-3005. doi: 10.1158/1535-7163.MCT-08-0411. Mol Cancer Ther. 2008. PMID: 18790780 Clinical Trial.

6

Cloning and structural characterization of the human histone deacetylase 6 gene.

Voelter-Mahlknecht S, Mahlknecht U. Voelter-Mahlknecht S, et al. Among authors: mahlknecht u. Int J Mol Med. 2003 Jul;12(1):87-93. Int J Mol Med. 2003. PMID: 12792815

7

Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression.

Mahlknecht U, Will J, Varin A, Hoelzer D, Herbein G. Mahlknecht U, et al. J Immunol. 2004 Sep 15;173(6):3979-90. doi: 10.4049/jimmunol.173.6.3979. J Immunol. 2004. PMID: 15356147

8

When the band begins to play: histone acetylation caught in the crossfire of gene control.

Mahlknecht U, Ottmann OG, Hoelzer D. Mahlknecht U, et al. Mol Carcinog. 2000 Apr;27(4):268-71. doi: 10.1002/(sici)1098-2744(200004)27:4<268::aid-mc4>3.0.co;2-p. Mol Carcinog. 2000. PMID: 10747290

9

Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins.

Bokelmann I, Mahlknecht U. Bokelmann I, et al. Among authors: mahlknecht u. Mol Med. 2008 Jan-Feb;14(1-2):20-7. doi: 10.2119/2007-00084.Bokelmann. Mol Med. 2008. PMID: 17973028 Free PMC article.

10

Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered.

Dahmke IN, Backes C, Rudzitis-Auth J, Laschke MW, Leidinger P, Menger MD, Meese E, Mahlknecht U. Dahmke IN, et al. Among authors: mahlknecht u. PLoS One. 2013 Dec 12;8(12):e81122. doi: 10.1371/journal.pone.0081122. eCollection 2013. PLoS One. 2013. PMID: 24349037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page